Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /603669

Lionco Pharmaceutical Group Co.,Ltd.

603669

• SSE: 603669 • Delayed

4.48CNY -1.5%

0.6630 USD

As of 19 June 2026, Lionco Pharmaceutical Group Co.,Ltd. has a market cap of $467.71M USD, ranking #15611 globally and #4909 in China. It ranks #1395 in the Healthcare sector, and #79 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

15611

Country Rank

4909

Sector Rank

1395

Industry Rank

Key Stats

Market Cap

$467.71MUSD

3.16B CNY

Enterprise Value

$485.89MUSD

3.28B CNY

Revenue (TTM)

$47.72MUSD

322.48M CNY

EBITDA (TTM)

-$9.2MUSD

-62.19M CNY

Net Income (TTM)

-$28.6MUSD

-193.24M CNY

EBITDA Margin

-19%

Profit Margin

-60%

PS Ratio

9.8

PB Ratio

5.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Ling Ping Tao open_in_new

Employees

436

Founded

2003

Website

lingkang.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.5%	7%	1.1%	-0.9%	-17%	5.4%	6.3%	-12%	-50%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603669 灵康药业集团股份有限公司 Class A ISIN: CNE1000022R8 Shares Out.: Shares Outstanding: 694.628M¹ Shares Float: 321.127M² TV: TradingView: SSE: 603669 SA: Stock Analysis: SHA: 603669 YF: Yahoo Finance: 603669.SS GF: Google Finance: SHA: 603669 BA: Barron's: 603669 MS: Morningstar: XSHG: 603669	4.48 CNY	TV: TradingView: SSE: 603669 SA: Stock Analysis: SHA: 603669 YF: Yahoo Finance: 603669.SS GF: Google Finance: SHA: 603669 BA: Barron's: 603669 MS: Morningstar: XSHG: 603669

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.88B 107.34B CNY 3K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.12B 61.6B CNY 2K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.23B 35.33B CNY 1K%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 801%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 600%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 487%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.2B 108.92B ILS 8K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 6K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.28B 1.06T INR 2K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.16B 1.05T INR 2K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.73B 7.57B EUR 2K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.55B 807.02B INR 2K%	23.1	India

chevron_leftBack